GSE158379
Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia
Mutations in SET binding protein 1 (SETBP1) are associated with poor outcomes in myeloid leukemias. In the Ras-driven leukemia, juvenile myelomonocytic leukemia, SETBP1 mutations are enriched in relapsed disease. We demonstrate that SETBP1 enhances the NRAS gene expression signature, driving upregulation of mitogen-activated protein kinase (MAPK) signaling and downregulation of differentiation pathways. Overall design: Comparison of gene expression in mouse bone marrow cells retrovirally expressing mutant SETBP1 and/or NRAS